The 9th edition of India Pharma Conference 2026 was organised on April 13–14, 2026 in New Delhi by Department of Pharmaceuticals under the Ministry of Chemicals & Fertilizers, in collaboration with Federation of Indian Chambers of Commerce and Industry and Indian Pharmaceutical Alliance.
The conference serves as a strategic platform to transform India’s pharmaceutical sector from a volume-driven industry to a value- and innovation-led global powerhouse, strengthening India’s position in the global healthcare ecosystem.
Theme of India Pharma 2026
“Discover in India: Leapfrogging Life-Sciences Innovation”
- Focus on innovation-driven growth in pharmaceuticals and life sciences
- Aims to position India as a global hub for cutting-edge research and drug development
- Emphasises healthcare access, innovation, and global health security
9th India Pharma Conference 2026 Highlights
Brought together:
- Policymakers
- Global industry leaders
- Researchers and innovators
Focus areas:
- Drug discovery
- Complex generics
- Biosimilars
- R&D ecosystem expansion
Showcased India’s strength in:
- Pharmaceutical manufacturing
- Global supply chain integration
About India Pharma Initiative
- Conceptualised in 2016 by Federation of Indian Chambers of Commerce and Industry in partnership with the Department of Pharmaceuticals
- Acts as a platform for industry–government dialogue
- Helps in:
- Identifying growth opportunities
- Addressing sectoral challenges
- Developing policy frameworks
Evolution of Themes
- 2016: Make in India – Are We on Track
- 2017: Responsible Healthcare
- 2018: Driving NextGen Pharmaceuticals
- 2019: Affordable Healthcare
- 2020: Quality & Affordable Healthcare
- 2021: Future is Now
- 2022: Vision 2047
- 2023: Innovation-led Value Creation
India’s Pharmaceutical Sector
- Rank:
- 3rd globally by volume
- 14th by value
- Contribution to GDP: ~1.7%
- Current size: ~$50 billion
- Target (2030): ~$130 billion
- Exports: $30+ billion
Global Role
- Led initiatives like Vaccine Maitri (300 million doses to ~100 countries)
India’s Biotechnology Sector
- Ranked Top 12 globally, 3rd in Asia-Pacific
- Current valuation: ~$137 billion
- Target: $300 billion by 2030
- Driven by innovation, startups, and R&D infrastructure
About Key Organisations
Federation of Indian Chambers of Commerce and Industry
- Established: 1927
- India’s largest apex business organisation
- Represents 2.5 lakh+ companies
Department of Pharmaceuticals
- Under Ministry of Chemicals & Fertilisers
- Promotes innovation, infrastructure, and Atmanirbhar Bharat in pharma
- Aligned with Viksit Bharat 2047 vision